Introduction
Procacitonin (PCT) is a peptide of 115 amino acids that produced by the C cells of the thyroid gland and other endocrine cells in the lung and intestine. It is one of the acute phase reactants that released in response to endotoxin or to the related cytokines that associated with bacterial infections. 1, 2 It is a useful and accurate diagnostic marker of sepsis, and it's used to guide the antibacterial therapy in infections. 3, 4 A diabetic foot syndrome (DFS) is a clinical condition characterized by ulceration, signs of inflammation and infections and in the presence or absence of gangrene. Wagner-Meggitt's classification was used for grading DFS. 5 This classification system has six grades (0-5) of lesions, the first four grades based on the physical depth of the lesion and the last two based on the gangrene extension. A strong correlations demonstrated between PCT levels and interleukin (IL)-1β, tumor necrosis factor (TNF)-α, and IL-6. 6 In infected diabetic foot ulcer, the serum levels of PCT is significantly higher than patients without infection with a sensitivity and specificity of 70% and 74%, respectively, making this measurement as a useful diagnostic marker for existence of the bacterial infection when it combined with other markers like c-reactive protein. 7 The levels of PCT tended to decrease significantly during the early phase of healing in patients with diabetic foot syndrome (DFS) and osteomyelitis and this reduction run in parallel with a reduction in the IL-6. 8 In non-bacterial infection, PCT acts as pro inflammatory marker and it is considered as a good prognostic biomarker, for example a significant high serum level of PCT in patients with ischemic stroke at the time of admission predicts a long-term poor prognosis. 9 Moreover, PCT and hs-CRP are found as independent predictors of long-term mortality in patients with acute ischemic stroke and acute heart failure. 10, 11 The rationale of this study is the changes in the PCT levels usually associated with changes in hs-CRP of whatever the pathological condition. Therefore, this study aimed to assess the simultaneous changes in the PCT and hs-CRP in DFS complicated type 1 and 2 diabetes.
Group I (n=30): Apparent healthy subjects served as a control Group II (n=70): T1D with FDS Group III (n=70): T2D with FDS Demographic data, medical history and treatment were collected in the center. Modifiable risk factors, events or complications, and current therapy were recorded. A person who reported smoking on admission was defined as current smoker. Height, weight, waist circumference, hip circumference were measured, and body mass index (BMI) was calculated using Quetlete's equation. Body mass index (kg/m 2 ) = weight (kg) / height 2 (m) Waist circumference (cm) and the waist to height (cm) ratio recorded. The blood pressure was measured on sitting position and the mean of three readings was taken. The mean arterial blood pressure was determined using the following equation: Mean arterial blood pressure (mmHg) = Diastolic + 1/3 pulse pressure Pulse pressure is equal to systolic-diastolic blood pressure Peripheral venous blood was drawn immediately after admission into plain test tubes, part of them were centrifuged at 2500 rpm for 10 min, and the sera were separated for determination of fasting serum glucose and lipid profile and the other uncentrifuged part was used for determination of HbA 1c (%) on the same day of collection. Part of sera were kept in deep freeze at -20°C for analysis of hs-CRP and precalcitonin. The determinants of lipid profile included fasting serum total cholesterol (TC), triglycerides (TG) and high density lipoprotein-cholesterol (HDL-c). The low density lipoprotein-cholesterol (LDL-c) and very low density lipoprotein-cholesterol (VLDL-c) were determined by using the following equations: VLDL-c = TG x 0.2 LDL-c = TC-(HDL-c + VLDL-c) 12 Quantitative determination of serum high sensitivity C-reactive protein (hs-CRP) and
Methods
This observational study was carried in the Center of Diabetes Mellitus in Erbil. The study was conducted according to the guidelines of the Declaration of Helsinki with approval from a local ethical review board. A consent form obtained from each patient before enrollment into the study. The entry criteria included DFS that complicated type 1 and 2 diabetes (T1D and T2D) patients treated with oral hypoglycemic agents and insulin according to the clinical status of the patient. The clinical examination of the patients as well as the grading of the diabetic foot manifestations were carried by the consultant endocrinologists at the diabetes center. The criteria of exclusion included a history of rheumatic conditions, hematological, neoplastic, renal, liver or thyroid diseases, or patients receiving treatment with anti-inflammatory drugs. The patients grouped according into:
PCT were carried on using the enzyme linked immunosorbent assay (ELISA) technique.
Statistical analysis
Data are expressed as number, percentages, and means ± SD. Unpaired difference between two means Student's t test, one way analysis of variance (ANOVA) post hoc Tukey (HSD) test and differences between percentages (whenever the data are presented as percentages) were used to look for the differences between the two groups and a simple (Pearson's) correlation test was used to detect the correlations between the inflammatory markers and other risk factors. For all tests, a two-tailed P ≤0.05 was considered statistically significant. Table 1 shows the characteristics of the participants. The number of males that presented with DFS is higher than the corresponding number of females with T1D and T2D. The mean age of T2D patients was significantly higher than the corresponding age of T1D patients or healthy subjects. There was no specific distribution of patients with FDS in respect to the residency. Group II showed significant longer duration of diabetes and higher glycemic indices compared with Group III. The results are expressed as number (%) and mean ± SD. † Probability of the statistical difference between Group I andGroup II; † † Probability of the statistical difference between Group I and III, † † † between Group II and III using unpaired Student t test, difference between percentages test and ANOVA post hocTuckey (HSD) test. Table 3 shows that systolic and pulse pressures among Group II patients were significantly higher than healthy subjects while the systolic, diastolic, pulse and mean arterial blood pressures were significantly higher in Group III patients compared with Group I and II. The results expressed as number (%) and mean ±SD. Probability of the statistical difference was calculated by using difference between percentages and unpaired Student (t) test. The results are expressed as mean ± SD. † Probability of the statistical difference between Group I and Group II; † † Probability of the statistical difference between Group I and III, † † † between Group II and III using unpaired Student t test, difference between percentages test and ANOVA post hoc Tuckey (HSD) test. (Figure 1 ). The results expressed as mean ± SD. The results are expressed as mean ± SD. † Probability of the statistical difference between Group I and Group II; † † Probability of the statistical difference between Group I and III, † † † between Group II and III using ANOVA post hocTuckey (HSD) test. Serum PCT levels in Group II (0.334±0.094 ng/ml) and Group III (1.11±0.47 ng/ml) were significantly (P <0.001) higher than Group I (Figure 2) . In Group II, serum procalcitonin levels are positively and significantly correlated with HbA1c (%) and in Group III correlated significantly with fasting serum glucose (Table 6 ). The results are expressed as correlation factor (r). The P value represented the two tailed calculation of simple correlation test. DFS grading among T2D compared with the T1D patients. Recent studies demonstrate that serum levels of PCT and hs-CRP are good biomarkers to distinct between infected and non-infected diabetic foot ulcer and they considered as a useful marker for diagnosis of DFS when the clinical signs are misleading. 7, 13 Radiological investigations including bones and joints X-rays do not carry based on the previous study that the changes in the serum levels of procalcitonin did not discriminate the bone infection. 14, 15 Moreover, the cardio-metabolic risk factors; body mass index, waist circumference, high blood pressure and dyslipidemia were significantly found in T2D patients who had significant high PCT and hs-CRP levels compared with T1D. On the other hand, there were insignificant correlations were demonstrated between PCT or hs-CRP with cardio-metabolic risk factors except the fasting serum glucose leveland the glycosylated hemoglobin. Our findings are in agreement with other studies. Mica et al reported a significant lower incidence of sepsis in obese individuals and there
Results
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The serum levels of hs-CRP are insignificantly correlated with glycemic indices or lipid profile in Group II and III (Table 7) . There was insignificant correlation between procalcitonin and hs-CRP in group II or Group III. The results are expressed as correlation factor (r). The P value represented the two tailed calculation of simple correlation test.
Discussion
The results of this study show that the serum levels of hs-CRP and PCT are significantly increased and attended higher levels among T2D patients compared with T1D. There is an insignificant correlation between serum levels of PCT with hs-CRP in both T1D and T2D. Fasting serum glucose and the glycosylated hemoglobin in T2D patients were significantly less thanT1D patients. Previous studies showed that the release of calcitonin from the adipose tissue did not trigger by the insulin like peptides which indicating no relation between glucose levels and PCT as shown in this study. 13 Therefore, the increased serum levels of PCT among T2D do not relate to the diabetic control. The increased levels of the PCT and hs-CRP are related to the grading of the DFS as this study showed that the significant high score of was insignificant differences in the PCT or hs-CRP between obese and non-obese individuals. 16 Abbasi et al., found that the normal range of plasma PCT levels was associated with obesity, insulin resistance and the features of the metabolic syndrome in the general population. 17 . In hypertensive patients managed with low dietary salts are more likely to have significant high PCT levels and this could explain our results that T2D patients have significant high PCT and blood pressure. 18 In severe sepsis, the lipoprotein levels are decreased by 50% and the PCT levels increased while this study shows that the picture of the lipoproteins levels is of metabolic derangement that found in diabetes mellitus. 19 Therefore, the infective theory of DFS plays a small role in the pathogenesis of DFS and the higher PCT levels are due to many causes other than sepsis. Limitations of the study are the radiological investigation of the foot bones and a microbiological study of tissue sloughing are not done. In conclusion that the simultaneous measurements of hs-CRP and PCT as inflammatory biomarkers are not necessary because there is nonsignificant correlation between them. The plasma levels of PCT are associated but not correlated with cardio-metabolic syndrome and such picture is significantly observed in T2D presented with DFS.
Conclusion
We conclude that the simultaneous measurements of hs-CRP and PCT as inflammatory biomarkers are not necessary because the correlation was not significant.
